Litcius/Paper detail

Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials

Filipe Colaço Mariz, Penelope Gray, Noemi Bender, Tiina Eriksson, Hanna Kann, Dan Apter, Jorma Paavonen, Emma Pajunen, Kristina Prager, Peter Sehr, Heljä‐Marja Surcel, Tim Waterboer, Martin Müller, Michael Pawlita, Matti Lehtinen

2021The Lancet Infectious Diseases60 citationsDOI

Topics & Concepts

MedicineVaccinationBivalent (engine)Vaccine trialCohortSeroprevalenceAntibodyClinical trialInternal medicineImmunologySerologyOrganic chemistryChemistryMetalCervical Cancer and HPV ResearchImmunotherapy and Immune ResponsesHead and Neck Cancer Studies
Sustainability of neutralising antibodies induced by bivalent or quadrivalent HPV vaccines and correlation with efficacy: a combined follow-up analysis of data from two randomised, double-blind, multicentre, phase 3 trials | Litcius